Not applicableNo Longer AvailableNCT05274204What this trial is testingIndividual Patient Expanded Access to CA102NWho this might be right forAdvanced or Metastatic Colorectal Cancer (mCRC) Holy Stone Healthcare Co., Ltd
Testing effectiveness (Phase 2)UnknownNCT05468177What this trial is testingCetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon CancerWho this might be right forColonic Neoplasms Tongji Hospital 66
Not applicableStudy completedNCT05424068What this trial is testingRehabilitation for People With Advanced CancerWho this might be right forAdvanced Breast CancerAdvanced Colorectal CancerCancer Rehabilitation University Health Network, Toronto 111
Testing effectiveness (Phase 2)UnknownNCT05799820What this trial is testingQL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRCWho this might be right forColorectal Carcinoma Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07204574What this trial is testingThe Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal CancerWho this might be right forCRC Chang Gung Memorial Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02337946What this trial is testingSafety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaWho this might be right forColorectal Carcinoma Takeda 164
Early research (Phase 1)Looking for participantsNCT06783569What this trial is testingA First-in-Human Escalation and Expansion Study of Patients With Advanced Solid TumorsWho this might be right forSolid TumorsGastric CancerEsophagogastric Juction Cancer+1 more JiaRay Group 94
Early research (Phase 1)Active Not RecruitingNCT06781983What this trial is testingSafety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Innate Pharma 145
Early research (Phase 1)Study completedNCT00873756What this trial is testingDulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Genentech, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01661972What this trial is testingPhase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer John Strickler, M.D. 63
Testing effectiveness (Phase 2)Looking for participantsNCT07003022What this trial is testingPhase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRCWho this might be right forColo-rectal CancerMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Fudan University 40
Not applicableEnded earlyNCT03073473What this trial is testingEvaluation of the NantHealth GPS Cancer Test in Patients With Advanced CancersWho this might be right forPancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more Cota Inc. 40
Not applicableUnknownNCT05304741What this trial is testingThe Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug ScreeningWho this might be right forColorectal Cancer Chongqing University Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07462650What this trial is testingDual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal CancerWho this might be right forColorectal Cancer MetastaticAdenocarcinoma of Colon Beijing Biotech 48
Testing effectiveness (Phase 2)UnknownNCT06384235What this trial is testingPhase II Clinical Study of LTC004 in Patients With mCRCWho this might be right forLocally Advanced or Metastatic CRC Letolab 30
Testing effectiveness (Phase 2)Ended earlyNCT00681876What this trial is testingPhase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerWho this might be right forColorectal Cancer Hellenic Oncology Research Group 16
Testing effectiveness (Phase 2)UnknownNCT06543836What this trial is testingCtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Not applicableWithdrawnNCT06929338What this trial is testingXDRIVE in Metastatic Colorectal CancerWho this might be right forMetastatic Colon AdenocarcinomaMetastatic Colon CancerMetastatic Rectal Adenocarcinoma+2 more First Ascent Biomedical Inc.
Early research (Phase 1)Looking for participantsNCT06983743What this trial is testingERAS-0015 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid Tumors Erasca, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT01619423What this trial is testingA Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal CancerWho this might be right forAdvanced Metastatic (Stage IV) Colorectal Cancer Egetis Therapeutics AB (publ) 186